Adrenocorticotropic hormone (ACTH) and melanocytestimulating hormones (a-MSH, b-MSH and g-MSH) are derived by enzymatic processing from proopiomelanocortin (POMC) and are collectively referred to as the melanocortins. Five melanocortin receptors (MC1-MC5 receptors) belonging to the seven-transmembrane G-protein-coupled receptor family have been reported to date.
These findings suggest that MC4 receptor blockade may be a useful approach for treating subjects with depressive and anxiety disorders. This hypothesis is supported by the demonstration in various rodent models of depression and anxiety that other MC4 receptor antagonists also exert antidepressant and anxiolytic effects. 19) Serotonin transporter blockade has been recognized as being effective for the treatment of depression, and selective serotonin reuptake inhibitors (SSRIs) have since become first-line drugs for the treatment of not only depression, but also anxiety disorders. 21) Although most patients are successfully treated with SSRIs, the existence of non-responders and of patients who respond slowly to the drug remains a drawback of SSRIs therapy. Therefore, much effort is being expended on the development of new antidepressants with mono-aminergic mechanisms of action. Previously, we reported that 2 (MCL0042; Fig. 1 ) exhibited relatively high affinities for both the MC4 receptor and the serotonin transporter. This compound, with its unique activity for both the MC4 receptor and the serotonin transporter, was also shown to exhibit antidepressant and anxiolytic-like effects. 18) Thus, drugs exhibiting a combination of MC4 antagonism and serotonin transporter inhibition might represent a new class of antidepressants.
In this paper, we report the synthesis and biological evaluation of various diphenylmethyl analogues in relation to their actions on the MC4 receptor. Moreover, selected compounds with a high affinity for the MC4 receptor were also examined to determine their affinity for the serotonin transporter.
Chemistry Charts 1-3 show the synthesis of compounds 12a-p and 18-20. Compounds 12a-p were prepared using two synthetic routes (Methods A and B) from fluoroacetophenone 7 via compound 11 23) (Charts 1, 2). The reaction of 7 with N-CO 2 Et-piperazine 14 followed by the reduction of the carbonyl group with NaBH 4 yielded 9. Chlorination of the hydroxyl group of 9 with thionyl chloride followed by coupling with N-R 1 -piperazine 15 in the presence of i Pr 2 NEt yielded 10. Removal of the ethoxycarbonyl group of 10 using KOH yielded 11. Compounds 11 were converted to 12b, 12c, 12e and 12h-o by treatment with alkyl halides (16 for 12c) in the presence of i Pr 2 NEt (Method A; Chart 1). Compound 12d was obtained by the hydrogenation of 12j using Pd-C as a catalyst. Furthermore, compound 12a was prepared by the reduction of 13, which had been prepared from 11 by condensation with carboxylic acid 17, using LiAlH 4 . Compounds 12f, 12g and 12p were also prepared from 11 by the same synthetic method as that for 12a (Method B; Chart 2).
Compounds 18-20 were also synthesized from compound 11 (Chart 3). The reaction of 11 with alkyl halide 21 in the presence of i Pr 2 NEt (yielding 18) and followed by hydrolysis yielded 19. Compound 20 was prepared from 19 by treatment with thionyl chloride, followed by treatment with aqueous NH 3 (Method C; Chart 3).
Results and Discussion
The affinities of all the compounds were evaluated by assessing their binding to the membranes of COS-1 cells expressing the human MC4 receptor and estimating the resulting affinities using the inhibition curve for [ ; the respective IC 50 values are shown in Tables 1 and 2 . In addition, selected compounds were tested for their affinity to the serotonin transporter (SERT) by assessing [ (Table 3) .
We previously reported that compound 1 (Fig. 1) , a bispiperazine compound with a carbonyl group that was identified in a high-throughput screening against an internal compounds library, exhibited moderate affinity for the MC4 receptor (IC 50 ϭ399 nM). 23) Bis-piperazine analogues with a carbonyl group (including 1), antagonists of the MC4 receptor, have also been reported by Arasasingham et al. 22) They also reported that bis-piperazine compound 6 (Table 1) , without the carbonyl group, exhibited almost no affinity for the MC4 receptor. These findings indicate that the carbonyl group is crucial for the binding of bis-piperazine compounds to the MC4 receptor. However, compound 1 has a beta amino ketone moiety in its structure, possibly resulting in the betaelimination of the amine part. Therefore, we attempted to design non-carbonyl compounds with a higher affinity for the MC4 receptor.
At first, to increase the binding affinity of non-carbonyl compound 6 for the MC4 receptor, we investigated a noncarbonyl compound with a longer length of an alkylene linker moiety between the piperazine ring and the benzene ring, designed based on the results of previously reported information regarding the structure-activity relationships (SARs) on the bis-piperazine compounds. 23) As expected, the resultant non-carbonyl compound 12a, with a four-carbon linker, exhibited a higher affinity for the MC4 receptor (12a: IC 50 ϭ1050 nM) than compound 6 with a three-carbon linker.
We next focused attention on p-electron of carbonyl group, and anticipated that a phenyl group having p-electron could be used as an alternative to the carbonyl group. We prepared compound 12b, in which a phenyl group was introduced into the benzyl position of compound 12a, and evaluated the affinity of the resultant compound for the MC4 receptor. Fortunately, compound 12b showed a much higher affinity for the MC4 receptor (IC 50 ϭ153 nM) than the lead compound 12a (IC 50 ϭ1050 nM) and also had a higher affinity than compound 1 (IC 50 ϭ399 nM). Therefore, we started to examine diphenylmethyl analogues with a higher affinity for the MC4 receptor.
Next, to increase the binding affinity for the MC4 receptor, we investigated an iso-propyl group at R 1 , because the isopropyl group was previously reported to be an optimized group in bis-piperazine analogues. 23) Moreover, we explored the effects of introducing fluorine atoms at the benzene ring on the binding affinity for the receptor. The resultant 12c, with the iso-propyl group and fluorine atoms at the benzene ring, showed a high affinity (IC 50 ϭ46.7 nM) for the MC4 receptor, and the iso-propyl group was employed in subsequent research efforts to explore diphenylmethyl analogues further.
We then explored the effects of benzene ring substituents in 12c on the binding affinity for the MC4 receptor. Substitution with a methyl (12f) or methoxy (12g) group at position 4 of the benzene ring resulted in a decrease in affinity for the MC4 receptor (12f: IC 50 ϭ97.7 nM and 12g: IC 50 ϭ224 nM), compared to that of a fluorine-substituted compound, 12c (IC 50 ϭ46.7 nM). Compound 12d substituted with a fluorine atom at position 3 of the benzene ring exhibited almost the same affinity for the MC4 receptor (IC 50 ϭ43.8 nM) as that of 12c with fluorine substitution at position 4, whereas substitution with a fluorine atom at position 2 resulted in a 2-fold decrease in the binding affinity (12e: IC 50 ϭ90.8 nM). These results suggest that substitution at positions 3 or 4 of the benzene ring might be more favorable for obtaining an increased binding affinity for the MC4 receptor than substitution at position 2.
Next, we examined diphenylmethyl analogues with other alkylene linkers between the piperazine ring and the diphenylmethyl moiety. At first, we focused on the conformational rigidity of the carbonyl group of compound 1 and introduced a carbon-carbon double bond to 12b. The resultant 12h, containing a carbon-carbon double bond, was tested for its affinity for the MC4 receptor. The result revealed that 12h exhibited a slightly higher affinity for the MC4 receptor (IC 50 ϭ92.0 nM) than 12b, without a carbon-carbon double bond. This finding encouraged us to optimize the binding affinity of this series of compounds containing a carbon-carbon double bond. Compounds 12i, 12j and 12k, substituted with a fluorine atom at positions 4, 3 or 2 of the benzene ring, respectively, exhibited similar affinities (IC 50 ϭ64.5, 45.1 and 68.2 nM, respectively) to those of compounds without a carbon-carbon double bond (12i vs. 12c, 12j vs. 12d, 12k vs. 12e). We next prepared compounds 12l-o substituted with a chlorine atom (12l), methoxy (12m), trifluoromethyl (12n) or trifluoromethoxy (12o) group at position 4 of the benzene ring and tested the binding affinities of these compounds for the MC4 receptor. The results showed that none of these compounds exhibited a higher affinity for the receptor than 12i (12l: IC 50 ϭ83.6 nM, 12m: IC 50 ϭ148 nM, 12n: IC 50 ϭ365 nM, 12o: IC 50 ϭ87.5 nM). These results suggest that a steric bulk at this position may not be well tolerated. We then investigated diphenylmethyl analogues with longer alkylene linkers between the piperazine ring and the diphenylmethyl moiety. The results showed that 12p, with a four-carbon linker, exhibited a similar affinity for the MC4 receptor (IC 50 ϭ52.2 nM) to 12i, with a three-carbon linker.
Since the introduction of the carbon-carbon double bond had no significant decrease of the binding affinity for MC4 receptor, we attempted to explore the effects of introducing R A (Chart 3) on the binding affinity for the receptor ( Table  2 ). The introduction of a methoxycarbonyl group at R A resulted in a slight increase in affinity for the MC4 receptor (18: IC 50 ϭ33.2 nM), compared with that of a non-substituted compound, 12c. Thus, a methoxycarbonyl group at R A had a favorable effect on the binding affinity for the MC4 receptor: however, a carboxyl or carbamoyl group at R A proved to be unfavorable (19: IC 50 ϭ2960 nM and 20: IC 50 ϭ618 nM).
Selected compounds with a high affinity for the MC4 receptor were also examined for their affinity to SERT (Table  3) . Although 3, 4 and 5 ( Fig. 1) , antagonists of the MC4 receptor previously reported by us, 23) and 12i had a higher affinity for the MC4 receptor than for SERT, 12c exhibited a high affinity (IC 50 ϭ10.7 nM) for SERT. Interestingly, the only difference between 12c and 12i was the presence of a carbon-carbon double bond, yet 12c exhibited a high affinity for SERT (IC 50 ϭ10.7 nM) while 12i had a low affinity for SERT (IC 50 ϭ444 nM). These results suggest that, in the case of these analogues, the carbon-carbon double bond might significantly impact the affinity for SERT. Furthermore, the finding that the affinities of 12c for both the MC4 receptor and SERT were greater than those of 2, which exhibited antidepressant and anxiolytic-like effects, 18) suggests that 12c may represent a promising tool for investigating the pathogenesis of stress-related disorders, such as depression and anxiety.
Conclusion
We have reported the synthesis and evaluation of a new series of MC4 receptor ligands, diphenylmethyl analogues. Removal of a carbonyl and methyl group from compound 1 provided our lead compound 12a. Structural optimization based on the SAR study around the piperazine side chain moiety led to the identification of diphenylmethyl analogues with high affinities for the MC4 receptor, namely, 12c and 18, which showed an over 20-fold higher affinity for the receptor than our lead compound 12a. Among these compounds, the introduction of a carbon-carbon double bond, such as in 12i, resulted in a higher selectivity for the MC4 receptor over SERT. In contrast, compound 12c without a carbon-carbon double bond exhibited high affinities for both the MC4 receptor and SERT. Considering that SSRIs are widely prescribed for the treatment of both depressive and anxiety disorders in clinical settings, this new class of compounds, such as 12c, displaying dual high affinities for both the MC4 receptor and SERT might also be useful for the treatment of these disorders.
Experimental
Melting points were determined on a Yanaco MP-500D melting point apparatus and are uncorrected. Proton nuclear magnetic resonance ( 1 H-NMR) spectra were obtained using a Varian Gemini 2000 (200 MHz) or Varian Unity Inova 300 (300 MHz). Chemical shifts are reported in parts per million relative to tetramethylsilane (TMS) as an internal standard. IR spectra were recorded on a Perkin-Elmer Spectrum One FT-IR spectrometer. Mass spectra (MS) were obtained on Micromass Platform LC (ES). High resolution spectra were recorded on a Micromass Q-TOF2 instrument. Elemental analyses were performed by a Perkin-Elmer 2400 or a Yanaco MT-6. Silica gel C-200 (100-200 mesh, Wako Pure Chemical) and Chromatorex NH (100-200 mesh, Fuji Silysia Chemical Ltd.) were used for column chromatography, using the solvent systems (volume ratios) indicated below.
General ( (؎)-1-[4,4-Bis(3-fluorophenyl)but-3-en-1-yl]-4-[2-(4-fluorophenyl)-2-(4-isopropylpiperazin-1-yl) ( fluorophenyl)-2-(4-isopropylpiperazin-1-yl) (
؎)-1-[4,4-Bis(4-fluorophenyl)but-3-en-1-yl]-4-[2-(4-fluorophenyl)-2-(4-isopropylpiperazin-1-yl)ethyl]piperazine 3 Maleate ((؎)-12i) (Ϯ)-

؎)-1-[4-(4-Chlorophenyl)-4-(4-fluorophenyl)but-3-en-1-yl]-4-[2-(4-
؎)-1-(1-(4-Fluorophenyl)-2-{4-[4-(4-fluorophenyl)-4-(4-methoxyphenyl)but-3-en-1-yl]piperazin-1-yl}ethyl)-4-isopropylpiperazine 3.8 Hydrochloride ((؎)-12m) (a Mixture of E and Z) (Ϯ)-12m was ob-
tained as a crystal. 12a, 12f, 12g and 12p (Method  B). (؎)-1-[2-(4-Fluorophenyl)-2-(4-methylpiperazin-1-yl) 29 (2H, m), 1.58-1.70 (2H, m) 26 mmol) and one drop of DMF in SOCl 2 (5 ml) was stirred at 80°C for 2 h, and concentrated in vacuo to obtain crude product as an amorphous. A mixture of the above crude product in a mixture of 25% aqueous NH 3 (15 ml) and THF (15 ml) was stirred at room temperature for 1 h. The mixture was partitioned between EtOAc and brine. The separated organic phase was dried over Na 2 SO 4 , filtered and concentrated in vacuo. 
